CLASS III Drug recall · Reported 14 Feb 2018 · FDA Enforcement Report

Ciclopirox Olamine Cream recalled by G & W Laboratories

G & W Laboratories is recalling Ciclopirox Olamine Cream USP, 0.77%, distributed nationwide in the US. The recall was initiated on 19 Jan 2018 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: a) 1002896, Exp 09/18; 1005797, Exp 05/19; 1006100, Exp 07/19; b) 1002561, Exp 06/18; 1002897, Exp 09/18; 1005798, Exp 05/19; 1006101, Exp 07/19; c) 1002898, Exp 10/18; 1004283, Exp 12/18; 1005837, Exp 05/19; 1006321, 1006322, Exp 07/19
NDC0713-0638
UPC0307130638159
Quantity recalled142,236 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0250-2018
FDA event ID
78974
Recalling firm
G & W Laboratories, South Plainfield, NJ
Manufacturer
Cosette Pharmaceuticals, Inc.
Classification
Class III
Status
Terminated
Recall initiated
19 Jan 2018
FDA classified
2 Feb 2018
Reported
14 Feb 2018
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Packaging Defects

Timeline

19 Jan 2018Recall initiated by company
2 Feb 2018Classified by FDA+14 days
14 Feb 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080.

Where it was distributed

Nationwide in the USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.

Which lots are affected?

Lot #: a) 1002896, Exp 09/18; 1005797, Exp 05/19; 1006100, Exp 07/19; b) 1002561, Exp 06/18; 1002897, Exp 09/18; 1005798, Exp 05/19; 1006101, Exp 07/19; c) 1002898, Exp 10/18; 1004283, Exp 12/18; 1005837, Exp 05/19; 1006321, 1006322, Exp 07/19

Where was it sold?

Nationwide in the USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from G & W Laboratories

All 6

Other Ciclopirox Olamine recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIICiclopirox Olamine Cream recalled by G & W LaboratoriesCiclopirox OlamineG & W LaboratoriesPackaging DefectsNationwide